Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL112 in AMI with Moderate Renal Impairment
NCT02742103Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of CSL112 in acute myocardial infarction (AMI), sponsored by CSL Limited. Started Aug 2016; status: completed.
02
Drugs
CSL112
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT02742103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742103.